The emerging roles of CDK12 in tumorigenesis
Open Access
- 27 October 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cell Division
- Vol. 12 (1), 7
- https://doi.org/10.1186/s13008-017-0033-x
Abstract
Cyclin-dependent kinases (CDKs) are key regulators of both cell cycle progression and transcription. Since dysregulation of CDKs is a frequently occurring event driving tumorigenesis, CDKs have been tested extensively as targets for cancer therapy. Cyclin-dependent kinase 12 (CDK12) is a transcription-associated kinase which participates in various cellular processes, including DNA damage response, development and cellular differentiation, as well as splicing and pre-mRNA processing. CDK12 mutations and amplification have been recently reported in different types of malignancies, including loss-of-function mutations in high-grade serous ovarian carcinomas, and that has led to assumption that CDK12 is a tumor suppressor. On the contrary, CDK12 overexpression in other tumors suggests the possibility that CDK12 has oncogenic properties, similarly to other transcription-associated kinases. In this review, we discuss current knowledge concerning the role of CDK12 in ovarian and breast tumorigenesis and the potential for chemical inhibitors of CDK12 in future cancer treatment.Funding Information
- Ministerstvo Zdravotnictví Ceské Republiky (16-34152A)
- Ministerstvo Zemědělství (RO0517)
This publication has 69 references indexed in Scilit:
- Interaction of Cyclin-Dependent Kinase 12/CrkRS with Cyclin K1 Is Required for the Phosphorylation of the C-Terminal Domain of RNA Polymerase IIMolecular and Cellular Biology, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Threonine-4 of mammalian RNA polymerase II CTD is targeted by Polo-like kinase 3 and required for transcriptional elongationThe EMBO Journal, 2012
- The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genesGenes & Development, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- A Genome-wide Camptothecin Sensitivity Screen Identifies a Mammalian MMS22L-NFKBIL2 Complex Required for Genomic StabilityMolecular Cell, 2010
- Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhingedGenes & Development, 2010
- CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1Genes & Development, 2010
- Genome profiling of ERBB2-amplified breast cancersBMC Cancer, 2010